Cardiovascular atherosclerosis and percutaneous transluminal interventions
Recruiting
- Conditions
- Coronary disease receiving coronary artery stentsCirculatory System
- Registration Number
- ISRCTN12810677
- Lead Sponsor
- Chang Gung Medical Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20000
Inclusion Criteria
1. Evidence of myocardial ischemia
2. >50% stenosis in a native coronary artery or in a bypass vein graft that was suitable for stenting
3. Over 20 years old
4. Had received coronary intervention
5. Patient and family members agreed to further follow-up
Exclusion Criteria
1. Severe multivessel disease requiring bypass surgery
2. Contraindication for aspirin, ticlopidine, clopidogrel or ticagrelor use
3. Patients who refused to undergo the procedure
4. Patients who refused further follow-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiac event (MACE) such as cardiac death, myocardial infarction (STEMI or NSTEMI), target lesion revascularization (TLR), stenting in a new lesion, and the need for emergency bypass surgery during long-term follow-up after coronary stentings
- Secondary Outcome Measures
Name Time Method Cardiovascular events during the follow-up period including total death (cardiac and non-cardiac), reinfarction (STEMI or NSTEMI), or a cerebrovascular accident (CVA) after coronary stentings